Mifepristone
Brand name: Korlym
Rank #184 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$83.3M
Total Cost
2,397
Total Claims
$83.3M
Total Cost
108
Prescribers
$35K
Cost per Claim
55
Beneficiaries
2,398
30-Day Fills
$771K
Avg Cost/Provider
22
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$83.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $83.3M total
🔎 Data Overview
At $34,733 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $770,889 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $1,513,746 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Mifepristone
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Benjamin Prohaska | Physician Assistant | Reno, NV | 101 | $3.1M |
| 2 | Amy Burmesch | Physician Assistant | Menomonee Falls, WI | 101 | $2.9M |
| 3 | Christopher Lucci | General Practice | Rockport, TX | 52 | $2.7M |
| 4 | Mark Borchelt | Endocrinology | Gulfport, MS | 42 | $2.5M |
| 5 | Benito Lopez | Physician Assistant | Edinburg, TX | 64 | $2.2M |
| 6 | Jamie Macknet | Nurse Practitioner | Loma Linda, CA | 32 | $2.1M |
| 7 | Eduardo Luna | Endocrinology | Edinburg, TX | 56 | $2.0M |
| 8 | Chioma Iweha | Internal Medicine | Peoria, AZ | 50 | $1.9M |
| 9 | Nelson Madrilejo | Internal Medicine | Bakersfield, CA | 37 | $1.8M |
| 10 | Mubashir Mahmood | Endocrinology | Knoxville, TN | 31 | $1.7M |
| 11 | Harold Miller | Endocrinology | Hammond, LA | 40 | $1.6M |
| 12 | Usah Lilavivat | Endocrinology | Sumter, SC | 46 | $1.5M |
| 13 | Mohammad Ijaz | Endocrinology | Zanesville, OH | 36 | $1.5M |
| 14 | David Brown | Internal Medicine | Rockville, MD | 47 | $1.5M |
| 15 | Brooke Mcadams | Endocrinology | Columbia, SC | 25 | $1.5M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 181 | Imatinib Mesylate (Imatinib Mesylate) | $85.0M | 40,908 |
| 182 | Clopidogrel Bisulfate (Clopidogrel) | $84.7M | 5,428,304 |
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
| 184 | Mifepristone (Korlym) | $83.3M | 2,397 |
| 185 | Insulin Nph Hum/Reg Insulin Hm (Humulin 70-30) | $82.3M | 177,501 |
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
| 187 | Certolizumab Pegol (Cimzia) | $79.9M | 11,784 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology